Table 3.
Gender Differences in the Prevalence, Demographic and Clinical Features of LH in DM Patients (Juvenile DM)
| Author (Year) | Male | Female | All | P-value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | Overall | LH Prevalence (%) | ||
| Singha et al (2021)27 | 20(43.48%) | 44(67.69%) | 31.25% | 26(56.52%) | 21(32.31%) | 55.32% | 46(50.55%) | 45(49.45%) | 91 | 50.55% | 0.0110 |
| McCann et al (2019)28 | 13(56.52%) | 28(50.00%) | 31.71% | 10(43.48%) | 28(50.00%) | 26.32% | 23(30.26%) | 53(69.74%) | 76 | 30.26% | 0.6290 |
| Blanco et al (2013)9 | 34(52.31%) | 21(38.89%) | 61.82% | 31(47.69%) | 33(61.11%) | 48.44% | 65(54.62%) | 54(45.38%) | 119 | 54.62% | 0.1438 |
| Conwell et al (2008)29 | 11(52.38%) | 13(44.83%) | 45.83% | 10(47.62%) | 16(55.17%) | 38.46% | 21(42.00%) | 29(58.00%) | 50 | 42.00% | 0.5977 |
| Lombardo et al (2022)37 | 64(66.67%) | 59(50.86%) | 52.03% | 32(33.33%) | 57(49.14%) | 35.96% | 96(45.28%) | 116(54.72%) | 212 | 45.28% | 0.0203 |
| Total | 142(56.57%) | 162(51.10%) | 46.71% | 109(43.43%) | 155(48.90%) | 41.29% | 251(45.80%) | 297(54.20%) | 548 | 45.80% | 0.1943 |